American Association of Individual Investors3d
Why Immunovant, Inc.’s (IMVT) Stock Is Down 11.06%
Immunovant, Inc.’s IMVT share price has dipped by 11.06%, which has investors questioning if this is right time to buy.
Teacher Retirement System of Texas Acquires 2,373 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Teacher Retirement System of Texas increased its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 18.5% ...
Nasdaq2d
Immunovant is Now Oversold (IMVT)
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Immunovant Inc (Symbol: IMVT) entered into oversold territory, hitting an RSI reading of 29 ...
Life Science Leader1dOpinion
Breaking Barriers: From Gendered Perceptions To Inclusive Leadership
Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity ...
Yahoo Finance6d
Immunovant, Inc. (IMVT)
Pete Salzmann, M.D., MBA, Chief Executive Officer of Immunovant, will be joined by Matt Gline, Chief Exec ...
Zura Bio (ZURA) Gets a Buy from Guggenheim
In a report released on March 26, Yatin Suneja from Guggenheim reiterated a Buy rating on Zura Bio (ZURA – Research Report), with a price ...
American Century Companies boosts stake in Biohaven, ETF Daily News says
American Century Companies has boosted its stake in Biohaven (BHVN) by 9.5% during Q4, ETF Daily News reports, citing a recent SEC filing. The firm owned 558,761 shares of Biohaven after purchasing an ...